The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk

The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk

The CHA2DS2-VASc risk score is an inexpensive and easy scoring system that is calculated by assigning a score of 1 point for each of the following conditions: congestive heart failure (ejection fraction 75 years. Metabolic Syndrome At inclusion, MetS was defined according to the National Cholesterol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista brasileira de cirurgia cardiovascular 2019-01, Vol.34 (5), p.535-541
Hauptverfasser: Aksoy, Fatih, Guler, Serdar, Kahraman, Fatih, Kuyumcu, Mevlüt Serdar, Bagcı, Ali, Bas, Hasan Aydın, Uysal, Dinçer, Varol, Ercan
Format: Artikel
Sprache:eng
Schlagworte:
Age
Atherosclerosis
Atrial Fibrilation
Blood pressure
Brain Ischemia
Calcification
CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Coronary Artery Disease
Diabetes
Ejection fraction
Heart failure
Heart surgery
Hyperglycemia
Hypertension
Laboratories
Metabolic Syndrome
Mortality
Normal distribution
Original
Pathogenesis
Stroke
Studies
SURGERY
Thromboembolism
Triglycerides
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The CHA2DS2-VASc risk score is an inexpensive and easy scoring system that is calculated by assigning a score of 1 point for each of the following conditions: congestive heart failure (ejection fraction 75 years. Metabolic Syndrome At inclusion, MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria as ≥3 of the following: (i) waist circumference ≥88 cm in women and ≥102 cm in men; (ii) elevated plasma triglycerides (≥1.7 mmol/L), or treatment for high triglycerides; (iii) low-plasma HDL-C (
ISSN:1678-9741
0102-7638
1678-9741
DOI:10.21470/1678-9741-2019-0062